COMTECH TELECOMMUNICATIONS CORP /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COMTECH TELECOMMUNICATIONS CORP /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $499.53M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $540.40M | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | $549.99M | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $486.24M | Oct 30, 2024 |
| FY2021 | Jul 31, 2021 | $145.81M | Oct 4, 2021 |
| FY2021 | Apr 30, 2021 | $139.38M | Oct 4, 2021 |
| FY2021 | Jan 31, 2021 | $161.29M | Oct 4, 2021 |
| FY2021 | Oct 31, 2020 | $135.22M | Oct 4, 2021 |
| FY2021 | Jul 31, 2020 | $149.67M | Oct 4, 2021 |
| FY2021 | Apr 30, 2020 | $135.12M | Oct 4, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jul 31, 2017 | $147.76M | Sep 27, 2017 |
| FY2017 | Apr 30, 2017 | $127.79M | Sep 27, 2017 |
| FY2017 | Jan 31, 2017 | $139.03M | Sep 27, 2017 |
| FY2017 | Oct 31, 2016 | $135.79M | Sep 27, 2017 |
| FY2017 | Jul 31, 2016 | $152.38M | Sep 27, 2017 |
| FY2017 | Apr 30, 2016 | $124.19M | Sep 27, 2017 |
| FY2017 | Jan 31, 2016 | $70.32M | Sep 27, 2017 |
| FY2017 | Oct 31, 2015 | $64.12M | Sep 27, 2017 |
| FY2017 | Jul 31, 2015 | $77.46M | Sep 27, 2017 |
| FY2017 | Apr 30, 2015 | $71.63M | Sep 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $127.87M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $157.18M | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | $184.46M | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $179.84M | Oct 30, 2024 |
| FY2021 | Jul 31, 2021 | $55.05M | Oct 4, 2021 |
| FY2021 | Apr 30, 2021 | $53.02M | Oct 4, 2021 |
| FY2021 | Jan 31, 2021 | $55.68M | Oct 4, 2021 |
| FY2021 | Oct 31, 2020 | $50.21M | Oct 4, 2021 |
| FY2021 | Jul 31, 2020 | $49.66M | Oct 4, 2021 |
| FY2021 | Apr 30, 2020 | $53.00M | Oct 4, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($155.30M) | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | ($99.99M) | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | ($26.90M) | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | ($33.05M) | Oct 30, 2024 |
| FY2021 | Jul 31, 2021 | $7.36M | Oct 4, 2021 |
| FY2021 | Apr 30, 2021 | $792.0K | Oct 4, 2021 |
| FY2021 | Jan 31, 2021 | $4.21M | Oct 4, 2021 |
| FY2021 | Oct 31, 2020 | ($85.84M) | Oct 4, 2021 |
| FY2021 | Jul 31, 2020 | $1.13M | Oct 4, 2021 |
| FY2021 | Apr 30, 2020 | ($3.99M) | Oct 4, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($139.10M) | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | ($79.89M) | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | ($14.66M) | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | ($33.75M) | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | ($68.30M) | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | $15.17M | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | $41.41M | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | $35.08M | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | $37.04M | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | ($576.0K) | Sep 26, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $17.41M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $24.08M | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | $48.63M | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $52.53M | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | $49.15M | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | $52.18M | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | $56.41M | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | $53.87M | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | $54.26M | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | $42.19M | Sep 26, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $143.49M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $123.20M | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | $120.00M | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $114.86M | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | $111.80M | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | $117.13M | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | $128.64M | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | $113.92M | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | $116.08M | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | $94.93M | Sep 26, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($8.29M) | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | ($54.50M) | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | ($4.43M) | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $2.00M | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | ($40.64M) | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | $52.76M | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | $68.03M | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | $50.34M | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | $66.92M | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | $15.08M | Sep 26, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $8.57M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $13.08M | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | $18.31M | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $19.62M | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | $16.04M | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | $7.23M | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | $8.79M | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | $8.64M | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | $8.15M | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | $5.67M | Sep 26, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $740.84M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $912.43M | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | $996.24M | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $974.30M | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | $993.11M | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | $929.65M | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | $887.71M | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | $845.16M | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | $832.06M | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | $921.20M | Sep 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $446.87M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $426.11M | Nov 10, 2025 |
| FY2024 | Jul 31, 2023 | $445.73M | Oct 30, 2024 |
| FY2023 | Jul 31, 2022 | $402.51M | Oct 12, 2023 |
| FY2022 | Jul 31, 2021 | $492.39M | Sep 29, 2022 |
| FY2021 | Jul 31, 2020 | $380.35M | Oct 4, 2021 |
| FY2020 | Jul 31, 2019 | $352.63M | Sep 29, 2020 |
| FY2019 | Jul 31, 2018 | $339.47M | Sep 24, 2019 |
| FY2018 | Jul 31, 2017 | $351.91M | Sep 26, 2018 |
| FY2017 | Jul 31, 2016 | $450.80M | Sep 27, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $104.42M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $306.25M | Nov 10, 2025 |
| FY2024 | Jul 31, 2023 | $438.30M | Oct 30, 2024 |
| FY2023 | Jul 31, 2022 | $466.59M | Oct 12, 2023 |
| FY2022 | Jul 31, 2021 | $500.72M | Sep 29, 2022 |
| FY2021 | Jul 31, 2020 | $549.30M | Oct 4, 2021 |
| FY2020 | Jul 31, 2019 | $535.08M | Sep 29, 2020 |
| FY2019 | Jul 31, 2018 | $505.68M | Sep 24, 2019 |
| FY2018 | Jul 31, 2017 | $480.15M | Sep 26, 2018 |
| FY2017 | Jul 31, 2016 | $470.40M | Sep 27, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $204.63M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $284.18M | Nov 10, 2025 |
| FY2024 | Jul 31, 2023 | $347.69M | Oct 30, 2024 |
| FY2023 | Jul 31, 2022 | $347.69M | Oct 12, 2023 |
| FY2022 | Jul 31, 2021 | $347.70M | Sep 29, 2022 |
| FY2021 | Jul 31, 2020 | $330.52M | Oct 4, 2021 |
| FY2020 | Jul 31, 2019 | $310.49M | Sep 29, 2020 |
| FY2019 | Jul 31, 2018 | $290.63M | Sep 24, 2019 |
| FY2018 | Jul 31, 2017 | $290.63M | Sep 26, 2018 |
| FY2017 | Jul 31, 2016 | $287.62M | Sep 27, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($6.90M) | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $103.58M | Nov 10, 2025 |
| FY2024 | Jul 31, 2023 | $238.91M | Oct 30, 2024 |
| FY2023 | Jul 31, 2022 | $278.68M | Oct 12, 2023 |
| FY2022 | Jul 31, 2021 | $333.00M | Sep 29, 2022 |
| FY2021 | Jul 31, 2020 | $417.27M | Oct 4, 2021 |
| FY2020 | Jul 31, 2019 | $420.33M | Sep 29, 2020 |
| FY2019 | Jul 31, 2018 | $405.19M | Sep 24, 2019 |
| FY2018 | Jul 31, 2017 | $385.14M | Sep 26, 2018 |
| FY2017 | Jul 31, 2016 | $383.62M | Sep 27, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $40.02M | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $32.43M | Nov 10, 2025 |
| FY2024 | Jul 31, 2023 | $18.96M | Oct 30, 2024 |
| FY2023 | Jul 31, 2022 | $21.65M | Oct 12, 2023 |
| FY2022 | Jul 31, 2021 | $30.86M | Sep 29, 2022 |
| FY2021 | Jul 31, 2020 | $47.88M | Oct 4, 2021 |
| FY2020 | Jul 31, 2019 | $45.58M | Sep 29, 2020 |
| FY2019 | Jul 31, 2018 | $43.48M | Sep 24, 2019 |
| FY2019 | Jul 31, 2017 | $41.84M | Sep 24, 2019 |
| FY2019 | Jul 31, 2016 | $66.81M | Sep 24, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | (6) | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | (4) | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | (1) | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | (1) | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | (2) | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | 0 | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | 1 | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | 1 | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | 0 | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | 0 | Sep 26, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | (6) | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | (4) | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | (1) | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | (1) | Oct 30, 2024 |
| FY2021 | Jul 31, 2021 | 0 | Oct 4, 2021 |
| FY2021 | Apr 30, 2021 | 0 | Oct 4, 2021 |
| FY2021 | Jan 31, 2021 | 0 | Oct 4, 2021 |
| FY2021 | Oct 31, 2020 | (3) | Oct 4, 2021 |
| FY2021 | Jul 31, 2020 | 0 | Oct 4, 2021 |
| FY2021 | Apr 30, 2020 | 0 | Oct 4, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $158.0K | Nov 10, 2025 |
| FY2025 | Jul 31, 2024 | $268.0K | Nov 10, 2025 |
| FY2025 | Jul 31, 2023 | $8.66M | Nov 10, 2025 |
| FY2024 | Jul 31, 2022 | $11.05M | Oct 30, 2024 |
| FY2023 | Jul 31, 2021 | $10.33M | Oct 12, 2023 |
| FY2022 | Jul 31, 2020 | $10.02M | Sep 29, 2022 |
| FY2021 | Jul 31, 2019 | $9.79M | Oct 4, 2021 |
| FY2020 | Jul 31, 2018 | $9.54M | Sep 29, 2020 |
| FY2019 | Jul 31, 2017 | $18.87M | Sep 24, 2019 |
| FY2018 | Jul 31, 2016 | $19.41M | Sep 26, 2018 |